Oghma Partners is pleased to share the release of its cell-based meat report.
To receive a copy of the report or if you would like to learn more about Oghma Partners and the work we do, please do get in touch via our “Contact us” link on our website or use the contact details available in the press release.
To view the full press release click here.
The second tertial of the year “T2” suggested a positive outlook for the remainder of the year.
To view the full press release click here.
Oghma Partners is pleased to announce that we have been awarded Best Boutique Food & Beverage Sector M&A Advisory Firm 2023 – UK
Oghma Partners is pleased to announce that we have been awarded Finance Monthly M&A Award in the category of Food and Beverage for UK.
Oghma Partners is pleased to announce that we have been awarded M&A Corporate Finance Advisory of the Year 2023 – UK by the Corporate Vision Magazine, annual Global Business Awards.
Oghma Partners is pleased to announce that we have been voted “Best Boutique Food & Beverage Sector M&A Advisory Firm 2023 – UK” in the Worldwide Finance Awards 2023 hosted by Acquisition International Magazine.
The first tertial of the year “T1” showed signs of recovery which is envisaged to be sustained through the rest of the year.
To view the full press release click here.
Oghma Partners is today pleased to announce that it has acted as the exclusive financial advisor to the shareholders of UK-based specialist ingredient business, Good Food Wines Limited (“GFW”), on the sale of its business to Kiril Mischeff Limited (“Kiril Mischeff”), a leading UK food and ingredient importer and supplier to the food and beverage industry.
To view the full press release click here.
Oghma Partners is pleased to share the release of its European Botanical Extracts Market and M&A Overview.
To view the full press release click here.
Oghma Partners is pleased to announce that it acted as the exclusive financial advisor to the shareholders of Algaia SA (“Algaia”), a French producer of seaweed-based solutions, on the sale of 100% of the issued share capital to J. Rettenmaier & Söhne GmbH + Co KG (“JRS”), a German fibre and hydrocolloid specialist.
To view the full press release click here.
